Distinct clinical and somatic mutational features of breast tumors with high-, low-, or non-expressing human epidermal growth factor receptor 2 status

Overview of attention for article published in BMC Medicine, April 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (87th percentile)
Above-average Attention Score compared to outputs of the same age and source (64th percentile)

So far, Altmetric has seen 27 X posts from 27 X users, with an upper bound of 63,163 followers.

RT @PTarantinoMD: Small study looking at the genomics of HER2-low vs HER2-0 MBC. Minor differences, dictated by the prevailing subtype: mor…

RT @BMCMedicine: Distinct clinical and somatic mutational features of #breasttumors with high-, low-, or non-expressing human epidermal gro…

RT @BMCMedicine: Distinct clinical and somatic mutational features of #breasttumors with high-, low-, or non-expressing human epidermal gro…

Distinct clinical and somatic mutational features of #breasttumors with high-, low-, or non-expressing human epidermal growth factor receptor 2 status. Read it here: https://t.co/N7mU6BGm9D https://t.co/hYQogjJNn4

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 23 additional X posts.